PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 USD
0,00%
(0,00) 1G
12 ott, 10:22:09 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per PTKFY in corso…
Cap. mercato
36,75 Bln
Vol. medio
1,96K
Volume
0,00
Max 52 sett.
16,36 USD
Min 52 sett.
7,63 USD
Beta
0,09
Azioni in circolazione
234,07 Mln
N. di dipendenti
13K
Cap. mercato
36,75 Bln
Vol. medio
1,96K
Volume
0,00
Max 52 sett.
16,36 USD
Min 52 sett.
7,63 USD
Beta
0,09
Azioni in circolazione
234,07 Mln
N. di dipendenti
13K
Articoli giornalistici
Da fonti web e partner giornalistici
ad-hoc-news.de
·
20 ore fa
Kalbe Farma launched an IDR 500 billion buyback of Kalbe Farma stock
ad-hoc-news.de
·
2 giorni fa
Kalbe Farma stock at EUR 0.04 with IDR 34.6 trillion market cap
ad-hoc-news.de
·
3 giorni fa
UBS keeps IDR 1,100 target for Kalbe Farma stock
Profilo
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Informazioni su PT Kalbe Farma Unsponsored Indonesia ADR